Physician

Stephen A Shore, M.D.

According to 2025 Medicare claims, Stephen Shore, M.D. (NPI: 1336235183) practices hematology/oncology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is CONSULTANTS IN MEDICAL ONCOLOGY & HEMATOLOGY, PC (NPI: 1043265820; TIN: 23-2826618) and primary practice location at 19008-3301.

Shore's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 112,453 HCPCS/CPT codes, and received $1,819,002 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 922 prescription claims across 160 beneficiaries totaling $1,861,392 in drug costs, led by Imbruvica (Ibrutinib). 2015 DME data shows 35 claims. Open Payments data shows 43 records totaling $5,634. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $781,261 to $1,819,002. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $496,140 to $1,861,392. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.